Abstract
A novel series of pyrazolo[1,5-b]pyridazines have been synthesized and identified as cyclin dependant kinase inhibitors potentially useful for the treatment of solid tumors. Modification of the hinge-binding amine or the C(2)- and C(6)-substitutions on the pyrazolopyridazine core provided potent inhibitors of CDK4 and demonstrated enzyme selectivity against VEGFR-2 and GSK3β.
| Original language | English |
|---|---|
| Pages (from-to) | 5758-5762 |
| Number of pages | 5 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 18 |
| Issue number | 21 |
| DOIs | |
| State | Published - Nov 1 2008 |
Keywords
- CDK2
- CDK4
- Cancer
- Cyclin-dependant kinase inhibitor
- GSK3β
- Pyrazolo[1,5-b] pyridazine
- VEGFR-2